Bayer Extends CEO’s Term Through 2029
Bayer's Supervisory Board has unanimously decided to extend the contract with the company's CEO, Bill Anderson, until March 31, 2029.
Bill Anderson
Bill Anderson to Be Bayer CEO from June 1
Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player Bayer has announced the appointment of a new CEO to succeed embattled incumbent Werner Baumann — a year before the end of the current chief executive’s regular term.
